Clinical Trial Update: Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin [NA]

View source ↗

Summary

A terminated clinical trial evaluating abdominal adipose tissue distribution in Type 2 diabetes patients treated for six months with pioglitazone or insulin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• Insulin (insulin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Type 2 Diabetes | NA | Status: TERMINATED